TIDMAZN
RNS Number : 7648X
AstraZeneca PLC
27 April 2023
27 April 2023 17:30 BST
Results of Annual General Meeting held on 27 April 2023
AstraZeneca PLC announced the results of the voting at its
Annual General Meeting (AGM) today. As proposed in the Notice of
AGM, all Resolutions were decided by poll vote. Resolutions 9 - 13
were passed as special resolutions; all other resolutions were
passed as ordinary resolutions.
Resolution Votes for % Votes % Votes cast Total Votes
of against of in total votes withheld
votes votes cast
cast cast as
a %
of
issued
share
capital
To receive the
Company's Accounts,
the Reports of
the Directors
and Auditor and
the Strategic
Report for the
year ended 31
1 December 2022 1,264,644,490 99.80 2,524,193 0.20 1,267,168,683 81.76 2,068,894
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
2 To confirm dividends 1,254,919,878 98.92 13,679,112 1.08 1,268,598,990 81.85 638,576
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To reappoint
PricewaterhouseCoopers
3 LLP as Auditor 1,260,792,714 99.39 7,718,080 0.61 1,268,510,794 81.85 726,500
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To authorise the
Directors to agree
the remuneration
4 of the Auditor 1,268,225,831 99.98 270,095 0.02 1,268,495,926 81.85 741,641
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Michel
Demaré as
5a a Director 1,241,496,328 97.88 26,829,809 2.12 1,268,326,137 81.84 911,430
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Pascal
5b Soriot as a Director 1,260,336,535 99.37 7,986,485 0.63 1,268,323,020 81.83 914,729
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Aradhana
5c Sarin as a Director 1,265,264,711 99.76 3,062,442 0.24 1,268,327,153 81.84 910,131
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Philip
Broadley as a
5d Director 1,259,273,602 99.29 9,043,851 0.71 1,268,317,453 81.83 920,114
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Euan
5e Ashley as a Director 1,268,022,043 99.98 282,266 0.02 1,268,304,309 81.83 924,629
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Deborah
5f DiSanzo as a Director 1,267,959,577 99.97 349,778 0.03 1,268,309,355 81.83 926,746
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Diana
Layfield as a
5g Director 1,268,027,536 99.98 274,653 0.02 1,268,302,189 81.83 935,378
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Sheri
5h McCoy as a Director 1,241,492,257 97.88 26,842,094 2.12 1,268,334,351 81.84 903,216
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Tony
5i Mok as a Director 1,261,574,735 99.97 322,367 0.03 1,261,897,102 81.42 7,338,922
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Nazneen
5j Rahman as a Director 1,266,284,904 99.85 1,870,104 0.15 1,268,155,008 81.82 1,082,559
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Andreas
5k Rummelt as a Director 1,268,030,928 99.98 285,793 0.02 1,268,316,721 81.83 920,846
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To re-elect Marcus
Wallenberg as
5l a Director 1,026,140,887 80.93 241,825,345 19.07 1,267,966,232 81.81 1,263,367
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To approve the
Annual Report
on Remuneration
for the year ended
6 31 December 2022 1,195,261,107 94.23 73,125,360 5.77 1,268,386,467 81.84 850,827
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To authorise limited
7 political donations 1,228,047,446 97.76 28,189,687 2.24 1,256,237,133 81.06 13,000,783
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To authorise the
Directors to allot
8 shares 1,166,174,071 91.95 102,088,563 8.05 1,268,262,634 81.83 966,964
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To authorise the
Directors to disapply
9 pre-emption rights 1,193,686,193 94.15 74,121,064 5.85 1,267,807,257 81.80 1,430,310
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To authorise the
Directors to further
disapply pre-emption
rights for acquisitions
and specified
10 capital investments 1,153,850,923 91.25 110,689,108 8.75 1,264,540,031 81.59 4,697,303
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To authorise the
Company to purchase
11 its own shares 1,254,158,039 98.92 13,730,760 1.08 1,267,888,799 81.81 1,348,767
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To reduce the
notice period
12 for general meetings 1,178,311,157 93.41 83,098,807 6.59 1,261,409,964 81.39 7,827,602
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
To adopt new Articles
of Association
13 of the Company 1,258,637,857 99.26 9,327,063 0.74 1,267,964,920 81.81 1,272,646
------------------------ -------------- ------- ------------ ------- -------------- --------- -----------
A copy of the resolutions passed at the AGM (other than
resolutions concerning ordinary business) has been submitted to the
National Storage Mechanism for publication, and will shortly be
available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
Issued capital
As at 25 April 2023, the number of issued shares of the Company
was 1,549,856,584 ordinary shares, which was the total number of
shares entitling the holders to attend and vote for or against all
of the resolutions at the AGM. In accordance with the Company's
Articles of Association, on a poll every member present in person
or by proxy has one vote for every share held.
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led
biopharmaceutical company that focuses on the discovery,
development, and commercialisation of prescription medicines in
Oncology, Rare Diseases, and BioPharmaceuticals, including
Cardiovascular, Renal & Metabolism, and Respiratory &
Immunology. Based in Cambridge, UK, AstraZeneca operates in over
100 countries and its innovative medicines are used by millions of
patients worldwide. Please visit astrazeneca.com and follow the
Company on Twitter @AstraZeneca .
Contacts
For details on how to contact the Investor Relations Team,
please click here . For Media contacts, click here .
Adrian Kemp
Company Secretary
AstraZeneca PLC
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGPPUQCCUPWGAM
(END) Dow Jones Newswires
April 27, 2023 12:30 ET (16:30 GMT)
Astrazeneca (LSE:0A4J)
Historical Stock Chart
From Apr 2024 to May 2024
Astrazeneca (LSE:0A4J)
Historical Stock Chart
From May 2023 to May 2024
